Health Condition 1: - Health Condition 2: O- Medical and Surgical
Conditions
Interventions
Intervention1: Administration of intravenous injection of three different doses (0.2 / 0.3 /0.4 mg/kg ) Cisatracurium: Study participants will be randomized into 3 groups.
Group A recieving 0.2 mg/kg
Sponsors
Niroo
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with American Society of Anaesthesiology class 1 or class 2 2. Age 18 to 60 years of either sex. 3. Mallampatti class 1 or class 2
Exclusion criteria
Exclusion criteria: 1. Patient with allergy to study drug 2. Patients with anticipated difficult intubation 3. Pregnant and lactating patients 4. Patients receiving drugs known to interact with neuromuscular blocking agents 5. Patients with neuromuscular disorder 6. Asthmatic and psychiatric patients on medication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Onset of action of study drug Intubating scoreTimepoint: After administration of study drug untill TOF score becomes zero at baseline. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Duration of action of the study drug 2. Haemodynamic and peripheral oxygen saturation 3. Side effectTimepoint: Outcome will be continuously recorded just after administration of drug,3 minutes,5minutes then every 5 minutes untill the sign of spontaneous breathing. | — |
Countries
India
Contacts
Public ContactDr Ashem Jack Meitei
Regional Institute of Medical Sciences
Outcome results
None listed